Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
about
Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells.Drug Resistance Driven by Cancer Stem Cells and Their Niche.RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.Structural Basis of ALDH1A2 Inhibition by Irreversible and Reversible Small Molecule Inhibitors.Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell.
P2860
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
@en
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
@nl
type
label
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
@en
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
@nl
prefLabel
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
@en
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
@nl
P2860
P356
P1476
Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
@en
P2093
David W Clark
Komaraiah Palle
P2860
P356
10.21037/ATM.2016.11.82
P577
2016-12-01T00:00:00Z